Scienture Drug Patent Portfolio

Scienture owns 2 orange book drugs protected by 3 US patents Given below is the list of Scienture's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11890273 Losartan liquid formulations and methods of use 07 Oct, 2041
Active
US12156869 Losartan liquid formulations and methods of use 07 Oct, 2041
Active
US12514854 Drug Products For Intranasal Administration And Uses Thereof 05 Feb, 2041
Active


Scienture's Family Patents


Family Patents



Scienture Drug List

Given below is the complete list of Scienture's drugs and the patents protecting them.


1. Arbli

Arbli is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11890273 Losartan liquid formulations and methods of use 07 Oct, 2041
(15 years from now)
Active
US12156869 Losartan liquid formulations and methods of use 07 Oct, 2041
(15 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Arbli's drug page


2. Rezenopy

Rezenopy is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12514854 Drug Products For Intranasal Administration And Uses Thereof 05 Feb, 2041
(14 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rezenopy's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List